Guiyuan, LV
资讯来源:信息技术学院发布时间:2014年01月08日 11:25
NAME |
Guiyuan, LV |
SEX |
Male |
BIRTH DATE |
Aug. 1954 |
|||||||
EMPLOYER |
Zhejiang Chinese Medical University |
|||||||||||
HIGHEST DEGREE |
Bachelor’s Degree |
TECHNICAL TITLE |
Professor |
|||||||||
SPECIALTY |
Chinese Herbology |
|||||||||||
DIRECTION |
Research of Chinese Medicine Pharmacology and New Product Development |
|||||||||||
MAILING ADDRESS |
Institute of Materia Medica, ZJ CMU Hangzhou 310053 |
|||||||||||
PHONE |
0571-86613601 |
MOBILE |
13906523168 |
|
lv.gy@263.net |
|||||||
CURRICULUM VITAE(University you graduated from, concurrent job, awards and honors, and experience as a postgraduate supervisor) Is a National Distinguished Teacher, National Outstanding Sci-Tech Worker, a person entitled to the special government allowance of the State Council, an Expert Having Outstanding Contributions in Zhejiang Province, and a qualified candidate for CAE academicians; Is a member of national drug review panel, national health product review panel, and national food safety review panel, and the review panel for CMA Sci-Tech 1stPrize/CACM Sci-Tech 1stPrize/CAIM Sci-Tech 1stPrize; (CAM: Chinese Medical Association; CACM: China Association of Chinese Medicine; CAIM: Chinese Association of Integrative Medicine); Is vice chair of the board of, and director and vice chair of, 12 academic organizations including WFCMS Chinese Medicine Pharmacology Branch, and deputy director of the editorial board for Chinese Herbs and editorial board member for another 6 academic journals including China Journal of Chinese Materia Medica; Also holds concurrent posts as director of the Institute of Materia Medica, ZJ CMU, leader of the Specialty of Chinese Medicine under Zhejiang “Top Priority” Specialties/Disciplines Program, responsible person of a National TCM level-III key lab, target trainee of the priority to enjoy the financial fund from Zhejiang 151 Talent Program, and young and middle-aged academic leader in colleges and universities in Zhejiang province that has the priority to receive fund; Is mainly engaged in the pharmacology of Chinese cardiovascular medicine and the development of new products; Has chaired more than 30 tasks and projects from national 973 Scheme, national 863 scheme, national major new drug innovative preparation project, national Sci-tech support scheme, NSCF influential research scheme, MoE priority projects, Zhejiang major projects for sci-tech development, major projects of Natural Science Foundation of Zhejiang Province, and Zhejiang TCM priority projects, with a fund totaling to RMB 20 million; The achievements of these researches have helped to gain 15 prizes, including the 2ndprize for National Sci-Tech Progress, the 1stprize for Zhejiang Science and Technology, the 1stprize for Zhejiang Sci-Tech Progress in the Field of TCM, and the 1stprize for Research Achievements in Colleges and Universities in Zhejiang Province; Has chaired the development of 8 new Chinese medicines against hypertension, myocardial ischemoia, fatty liver, uric acid, and gastric ulcer and promoting would healing, for which 1 national drug license/production approval, 3 clinical research approvals, and 2 national patents for invention have been granted to date; Has completed the editing of 7 national textbooks such as “Pharmacology” and “The Development of New TCM Drugs” as chief editor; Has trained 2 post-doctors and 75 doctors and masters in total, and now is mentoring 10 doctoral candidates and 25 graduate candidates. |
Copyright ? 2011 Zhejiang Chinese Medical University